Conference
Earn CE
Free Samples
Magazine
Subscribe
Videos
Solutions Lab
Macro/Op-Ed
Practice
Science & Tech
Money
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Dental Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Allakos Inc
(NQ:
ALLK
)
0.6793
-0.0337 (-4.73%)
Streaming Delayed Price
Updated: 2:25 PM EDT, Aug 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Allakos Inc
< Previous
1
2
3
4
5
Next >
ALLK Stock Earnings: Allakos Beats EPS for Q2 2024
August 07, 2024
ALLK stock results show that Allakos beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Allakos Provides Business Update and Reports Second Quarter 2024 Financial Results
August 07, 2024
From
Allakos Inc.
Via
GlobeNewswire
Allakos Announces Positive Results from its Ongoing Phase 1 Trial of AK006 in Healthy Volunteers, with AK006 Demonstrating High Receptor Occupancy on Mast Cells and a Favorable Safety Profile
June 25, 2024
From
Allakos Inc.
Via
GlobeNewswire
Allakos Announces First Patient Dosed in Phase 1 Trial of AK006 in Chronic Spontaneous Urticaria
May 28, 2024
From
Allakos Inc.
Via
GlobeNewswire
ALLK Stock Earnings: Allakos Meets EPS for Q1 2024
May 09, 2024
ALLK stock results show that Allakos met analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
ALLK Stock Earnings: Allakos Misses EPS for Q4 2023
March 14, 2024
ALLK stock results show that Allakos missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Where Allakos Stands With Analysts
December 18, 2023
Via
Benzinga
Allakos Provides Business Update and Reports First Quarter 2024 Financial Results
May 09, 2024
From
Allakos Inc.
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
May 03, 2024
Pre-market stock movers are worth checking out this morning as we dive into all of the biggest news moving shares on Friday!
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
May 01, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 15, 2024
We are starting the trading week with a dive into the biggest pre-market stock movers worth keeping tabs on for Monday morning!
Via
InvestorPlace
What 4 Analyst Ratings Have To Say About Allakos
November 28, 2023
Via
Benzinga
3 Biotech Stocks to Dump Before They Go to Zero
April 09, 2024
These biotech stocks to sell are burning through cash at an alarming rate and seem destined for zero, making them prime targets for selling.
Via
InvestorPlace
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
March 14, 2024
From
Allakos Inc.
Via
GlobeNewswire
Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024
February 26, 2024
From
Allakos Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 14, 2024
Via
Benzinga
Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition
February 12, 2024
From
Allakos Inc.
Via
GlobeNewswire
Netflix To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Wednesday
January 17, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 17, 2024
Via
Benzinga
Gold Down 1%; PNC Financial Posts Upbeat Earnings
January 16, 2024
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 350 points on Tuesday. The Dow traded down 0.93% to 37,243.85 while the NASDAQ fell 0.58% to 14,885.45. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 16, 2024
Via
Benzinga
Crude Oil Edges Lower; Morgan Stanley Posts Upbeat Revenue
January 16, 2024
U.S. stocks traded mostly lower midway through trading, with the Dow Jones index falling more than 150 points on Tuesday. The Dow traded down 0.46% to 37,421.80 while the NASDAQ fell 0.02% to...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Is Allakos (ALLK) Stock Down 57% Today?
January 16, 2024
Allakos stock is falling hard on Tuesday as investors in ALLK react to two of the company's Phase 2 clinical trials failing.
Via
InvestorPlace
Trial Setback: Allakos Drops Lead Skin Disorder Candidate, Cuts Workforce By 50%
January 16, 2024
Allakos reports disappointing topline data from phase 2 trials for lirentelimab in atopic dermatitis and chronic spontaneous urticaria. Company undergoes restructuring to focus on AK006, extending cash...
Via
Benzinga
Dow Dips 200 Points; Goldman Sachs Earnings Top Views
January 16, 2024
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 200 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.56% to 37,384.20 while the NASDAQ...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 16, 2024
Via
Benzinga
Allakos Announces a Restructuring to Focus on Development of AK006
January 16, 2024
From
Allakos Inc.
Via
GlobeNewswire
Allakos Announces Phase 2 Lirentelimab Trials in Atopic Dermatitis and Chronic Spontaneous Urticaria Did Not Meet Their Primary Endpoints
January 16, 2024
From
Allakos Inc.
Via
GlobeNewswire
Allakos Analyst Turns Bullish, Sees 'Significant Upside' If Study Results Are Positive
December 18, 2023
Shares of Allakos Inc (NASDAQ: ALLK) were climbing in early trading on Monday.
Via
Benzinga
Allakos Provides Business Update and Reports Third Quarter 2023 Financial Results
November 13, 2023
From
Allakos Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.